Duration of Dual Antiplatelet Therapy After Carotid Artery Stenting
For patients who undergo carotid artery stenting (CAS) after stroke, dual antiplatelet therapy (DAPT) with aspirin and clopidogrel should be continued for 1-3 months post-procedure, followed by lifelong single antiplatelet therapy.
Recommended DAPT Duration
The evidence supports a relatively short duration of DAPT after CAS, balancing thrombotic prevention against hemorrhagic risk:
Standard duration: 1-3 months 1
- Most commonly 4-6 weeks for single-layer stents
- Up to 3 months for mesh or dual-layer stents 2
After DAPT completion: Transition to single antiplatelet therapy (aspirin 75-100 mg daily OR clopidogrel 75 mg daily) indefinitely 3, 2
Evidence Supporting Shorter Duration
Recent high-quality research demonstrates that 3-month DAPT is as effective as longer durations while reducing bleeding complications:
A 2025 nationwide Korean cohort study of 12,034 CAS patients found no significant difference in ischemic stroke, gastrointestinal bleeding, or intracranial hemorrhage between short-DAPT (90 days to <6 months) versus long-DAPT groups 4
A 2025 propensity-matched analysis showed 3-month DAPT had similar efficacy but significantly lower hemorrhagic complications compared to extended DAPT (HR 6.21 for hemorrhage with >3-month DAPT, p=0.014) 5
A 2024 angioscopic study demonstrated complete neointimal coverage in 18 of 19 patients at 2 months post-CAS, supporting the adequacy of 2-month DAPT duration 6
Hemorrhagic Risk Considerations
The risk of bleeding increases substantially with prolonged DAPT:
- Extracranial hemorrhage rate is nearly 6-fold higher while on DAPT (6.50% vs 1.16% per patient-month after discontinuation) 7
- Hemorrhagic complications occur at 1.16% per person-month during DAPT versus 0.49% after discontinuation 7
- The MATCH trial demonstrated a 1.3% absolute increase in life-threatening bleeding with prolonged DAPT 1
Practical Implementation Algorithm
Pre-procedure:
- Load with clopidogrel 300-600 mg and aspirin 160-325 mg 8
- Ideally start at least 1 week before CAS if elective 6
Post-procedure DAPT regimen:
- Aspirin 75-100 mg daily + Clopidogrel 75 mg daily 1
- Duration: 1-3 months (typically 4-6 weeks for standard stents, up to 3 months for complex/mesh stents)
After DAPT period:
- Transition to single antiplatelet therapy indefinitely
- Aspirin 75-100 mg daily OR clopidogrel 75 mg daily 3, 2
Special Considerations
Patients on anticoagulation: If the patient requires oral anticoagulation (e.g., atrial fibrillation), the approach differs significantly. These patients often receive single antiplatelet therapy plus anticoagulation rather than DAPT to minimize bleeding risk 9, 10. However, this may be associated with higher rates of in-stent stenosis, particularly with DOACs 10.
High ischemic risk patients: While some may consider extending DAPT beyond 3 months in very high-risk cases, the evidence does not support routine extension given the increased hemorrhagic complications without clear ischemic benefit 5, 4, 7.
Timing after acute stroke: For patients undergoing emergent CAS in the setting of acute stroke with tandem occlusion, early DAPT initiation (<12 or <24 hours) did not modify the risk of stent occlusion/restenosis or symptomatic intracranial hemorrhage compared to delayed initiation 11.
Critical Pitfall to Avoid
Do not continue DAPT indefinitely after CAS. Unlike the acute stroke setting where short-term DAPT (21-30 days) is recommended for minor stroke/high-risk TIA 8, the post-CAS period requires only 1-3 months of DAPT before transitioning to single antiplatelet therapy. Prolonging DAPT beyond this period significantly increases hemorrhagic complications without proven ischemic benefit 5, 4, 7.